Could a cannabis pill calm Alzheimer's agitation?

NCT ID NCT05543681

Recruiting now Symptom relief Sponsor: IGC Pharma, LLC Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a new oral medication called IGC-AD1, which contains THC (the main active compound in cannabis) and melatonin, can safely reduce agitation in people with Alzheimer's disease. It will involve about 164 participants aged 60 and older who have significant, persistent agitation related to their dementia. The goal is to see if this treatment improves agitation symptoms over a 42-day period compared to a placebo.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

BayCare Health System Inc.
RECRUITING

St. Petersburg, Florida, 33705, United States
Baycrest Academy, University of Toronto
RECRUITING

Toronto, Ontario, ON M6A 2E1, Canada
Butler Hospital, Brown University
RECRUITING

Providence, Rhode Island, 02906, United States
ClinCloud, LLC
ACTIVE_NOT_RECRUITING

Maitland, Florida, 32751, United States
ClinCloud, LLC
RECRUITING

Melbourne, Florida, 32940, United States
Dent Neurosciences Research Center
RECRUITING

Amherst, New York, 02459, United States
Dominion Medical Associates, Inc.
RECRUITING

Richmond, Virginia, 23219, United States
Douglas Hospital Research Center, McGill university
RECRUITING

Montreal, Quebec, H4H 1R3, Canada
Global Medical Institutes Florida, LLC
RECRUITING

Miami, Florida, 33125, United States
Grupo de Neurociencias de Antioquia, Universidad de Antioquia
ACTIVE_NOT_RECRUITING

Medellín, Antioquia, Colombia
Hamilton Health Sciences , Mcmaster University
RECRUITING

Hamilton, Ontario, L8M 1W9, Canada
Ichor Research
RECRUITING

Syracuse, New York, 13210, United States
Instituto Sanacoop
COMPLETED

Bayamón, Bayamón, 00961, Puerto Rico
Integrative Clinical Trials, LLC
NOT_YET_RECRUITING

Brooklyn, New York, 11229, United States
Island Health Authorities
RECRUITING

Victoria, British Columbia, V8R 1J8, Canada
Lynn Health Science Institute (LHSI)
RECRUITING

Oklahoma City, Oklahoma, 73112, United States
MedStar Franklin Square Medical Center Neurology
RECRUITING

Baltimore, Maryland, 21237, United States
Medstar Georgetown University Hospital Neurology
RECRUITING

Clinton, Maryland, 20735, United States
Medstar Montgomery Medical Center
RECRUITING

Olney, Maryland, 20832, United States
Miami Jewish Health
RECRUITING

Miami, Florida, 33137, United States
Neurostudies Inc.
RECRUITING

Port Charlotte, Florida, 33952, United States
SCB Research Center
RECRUITING

Bayamón, 00961, Puerto Rico
Senior Adults Specialty Research
RECRUITING

Austin, Texas, 78757, United States
Tandem Intermediate, LLC
RECRUITING

Metairie, Louisiana, 70006, United States
Tekton Research LLC
RECRUITING

St Louis, Missouri, 63128, United States
University of Puerto Rico
RECRUITING

Rio Piedras, 00935, Puerto Rico
University of South Florida Department of Psychiatry and Behavioral Neurosciences
RECRUITING

Tampa, Florida, 33613, United States
Visionary Investigators Network
RECRUITING

Miami, Florida, 33133, United States

Conditions

Explore the condition pages connected to this study.

AGGRESSION AGITATION,PSYCHOMOTOR ALZHEIMER DISEASE CARE GIVING BURDEN NPS